FDP
NBIX icon

Financiere des Professionnels’s Neurocrine Biosciences NBIX Stock Holding History

Financiere des Professionnels’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Hold
10,302
– – 0.1% 160
2026
Q1 		$1.36M Sell
10,302
-695
-6% -$92.2K 0.08% 175
2025
Q4 		$1.56M Buy
10,997
+2,132
+24% +$309K 0.09% 163
2025
Q3 		$1.24M Buy
8,865
+3,324
+60% +$450K 0.07% 164
2025
Q2 		$696K Buy
+5,541
New +$635K 0.04% 184

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Financiere des Professionnels's NBIX Position: Q2 2026 in Review

Financiere des Professionnels held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 10,302 shares worth $1.74M. The position accounts for 0.1% of the portfolio, ranked #160.

Financiere des Professionnels first reported a position in NBIX in Q2 2025 and has held it in 5 quarters since. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Financiere des Professionnels held 10,302 shares of Neurocrine Biosciences worth $1.74M as of Q2 2026.
  • Financiere des Professionnels left its Neurocrine Biosciences share count unchanged in Q2 2026.
  • Neurocrine Biosciences made up 0.1% of Financiere des Professionnels's portfolio in Q2 2026, its #160 holding.
  • Financiere des Professionnels first reported a position in Neurocrine Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.